References
- ChadwickDValproate in the treatment of partial epilepsiesEpilepsia199435Suppl 5S96S988039481
- KenyonKMintzerSNeiMCarbamazepine treatment of generalized tonic-clonic seizures in idiopathic generalized epilepsySeizure201423323423624370318
- KwanPBrodieMJEarly identification of refractory epilepsyN Engl J Med2000342531431910660394
- CardarelliWJSmithBJThe burden of epilepsy to patients and payersAm J Manag Care20101612 SupplS331S33621517648
- Emich-WideraELikusWKazekBCYP3A5*3 and C3435T MDR1 polymorphisms in prognostication of drug-resistant epilepsy in children and adolescentsBiomed Res Int2013201317
- KumariRLakhanRGargRKKalitaJMisraUKMittalBPharmacogenomic association study on the role of drug metabolizing, drug transporters and drug target gene polymorphisms in drug-resistant epilepsy in a north Indian populationIndian J Hum Genet201117Suppl 1S3221747585
- BrodieMEngelJLeePde BoerHEuropean white paper on epilepsy-Call to actionEpilepsia200344412790881
- KwanPBrodieMJEffectiveness of first antiepileptic drugEpilepsia200142101255126011737159
- KasperaviciuteDSisodiyaSMEpilepsy pharmacogeneticsPharmacogenomics200910581783619450130
- CatterallWAStructure and function of voltage-gated sodium channels at atomic resolutionExp Physiol2014991355124097157
- CatterallWAChannelsSSodium channels, inherited epilepsy, and antiepileptic drugsAnnu Rev Pharmacol Toxicol20145431733824392695
- ParkerDSandersEJBurghardtKJPharmacogenetics of antiepileptic drugs: A brief reviewMent Health Clin201661283429955444
- KwanPPoonWSNgHKMultidrug resistance in epilepsy and polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, and SCN3A: correlation among phenotype, genotype, and mRNA expressionPharmacogenet Genomics2008181198999818784617
- BaumLHaerianBSNgHKCase-control association study of polymorphisms in the voltage-gated sodium channel genes SCN1A, SCN2A, SCN3A, SCN1B, and SCN2B and epilepsyHum Genet2014133565165924337656
- WangPZhouQShengYTangBLiuZZhouBAssociation between two functional SNPs of SCN1A gene and efficacy of carbamazepine monotherapy for focal seizures in Chinese Han epileptic patientsZhong Nan Da Xue Xue Bao Yi Xue Ban201439543344124921390
- LakhanRKumariRMisraUKKalitaJPradhanSMittalBDifferential role of sodium channels SCN1A and SCN2A gene polymorphisms with epilepsy and multiple drug resistance in the north Indian populationBr J Clin Pharmacol200968221422019694741
- EbrahimiAHoushmandMTonekaboniSHFallah Mahboob PassandMSZainaliSMoghadasiMTwo novel mutations in SCN1A gene in Iranian patients with epilepsyArch Med Res201041320721420682179
- TateSKDepondtCSisodiyaSMGenetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoinProc Natl Acad Sci U S A2005102155507551215805193
- AbeTSeoTIshitsuTNakagawaTHoriMNakagawaKAssociation between SCN1A polymorphism and carbamazepine-resistant epilepsyBr J Clin Pharmacol200866230430718489610
- MargariLLegrottaglieARVincentiAAssociation between SCN1A gene polymorphisms and drug resistant epilepsy in pediatric patientsSeizure201855303529353705
- BaoYLiuXXiaoZAssociation between two SCN1A polymorphisms and resistance to sodium channel blocking AEDs: a meta-analysisNeurol Sci20183961065107229582177
- DeeparaniTPillaiMRElavazhaganTDetection of MTHFR C677T and A1298C gene polymorphism in congenital heart diseaseMiddle-East J Scientific Res200942127132
- DordevićSKilibardaVStojanovićTDetermination of carbamazepine in serum and saliva samples by high performance liquid chromatography with ultraviolet detectionVojnosanit Pregl200966534735219489468
- EbidAHAhmedMMMohammedSATherapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective studyTher Drug Monit200729330531217529887
- HaerianBSBaumLKwanPTanHJRaymondAAMohamedZSCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysisPharmacogenomics201314101153116623859570
- TateSKSinghRHungCCA common polymorphism in the SCN1A gene associates with phenytoin serum levels at maintenance dosePharmacogenet Genomics2006161072172617001291